Carrageenan – Safe Food Additive or Health Hazard?
Table of Contents 12
This article is professional premium content (PRO) provided in its entirety.
A comprehensive examination of carrageenan: composition, origin, and physicochemical properties
Functional applications of carrageenan in the food industry: properties, mechanisms of action, and technological benefits
The pharmaceutical sector: utilization of carrageenan in medicinal formulations
The cosmetics sector: applications of carrageenan in skincare and hygiene formulations
Carrageenan’s impact on human health: Current evidence and safety guidelines
The impact of carrageenan on gastrointestinal function and potential health implications
Possible carcinogenic properties of carrageenan and current scientific consensus
Carrageenan and hypersensitivity reactions: risk assessment and clinical symptom analysis
The impact of carrageenan on systemic glucose regulation
Official assessments and recommendations from public health bodies regarding the use of carrageenan as a food additive
European Authority for Food Safety
The European Food Safety Authority (EFSA) concluded that the food additive denoted by the code E407—carrageenan—can be safely employed in foodstuffs formulated for the general population across most demographic brackets. Nonetheless, regulatory authorities highlighted the necessity for continued, in-depth scientific evaluations concerning potential physiological outcomes of its ingestion by neonates under sixteen weeks of age. Within this toxicological review, EFSA scientific panels noted critical data deficiencies in existing empirical documentation regarding infant gastrointestinal physiology. Consequently, in 2018, EFSA released an official call for data directed at manufacturers, academic research centers, and food supply stakeholders to supply updated, rigorous toxicological evidence facilitating refinement of existing consumer safety parameters (source: EFSA, 2018 Report).
Concurrently, the Joint FAO/WHO Expert Committee on Food Additives (JECFA), operating under the auspices of the United Nations Food and Agriculture Organization and the World Health Organization, reaffirmed that carrageenan poses no systemic health risks to consumers under established food processing standards. In its comprehensive 2014 re-evaluation, the Committee assigned an Acceptable Daily Intake (ADI) of "not specified" for the adult population, signifying that under contemporary regulatory thresholds, dietary exposure does not present toxicological hazard to adult health (data: JECFA, 2014).
The United States Food and Drug Regulatory Authority
Want to apply these guidelines in your daily diet?
Our smart diet generator creates a tailored meal plan in 3 minutes based on the recommendations in this article.
Call for technical and toxicological data on carrageenan (E 407) for uses in foods for all population groups including infants below 16 weeks of age, efsa.europa.eu/en/consultations/call/call-technical-and-toxicological-data-carrageenan-e-407-uses-foods (24.11.2024). Carrageenan, fao.org/fileadmin/user_upload/jecfa_additives/docs/Monograph1/Additive-117.pdf (24.11.2024). efsa.europa.eu/en/consultations/call/call-technical-and-toxicological-data-carrageenan-e-407-uses-foods (24.11.2024). CFR - Code of Federal Regulations Title 21, accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=172.626 (24.11.2024). Komisarska P. et al., Carrageenan as a Potential Factor of Inflammatory Bowel Diseases, „Nutrients” 2024, 16(9), 1367. Kular H., Dean J., Cook V., A case of carrageenan allergy in a pediatric patient, „Annals of Allergy, Asthma & Immunology” 2018, 121, 119. Kulczyński B., Karagen (E407): czy i dla kogo może być szkodliwy?, vitapedia.pl/karagen-e407 (24.11.2024). Liu F. et al., Food-grade carrageenans and their implications in health and disease, „Comprehensive Reviews in Food Science and Food Safety” 2021, 20(4), 3918–3936. López-Hortas L. et al., Applying Seaweed Compounds in Cosmetics, Cosmeceuticals and Nutricosmetics, „Marine Drugs” 2021, 19(10), 552. Pacheco-Quito E.M., Ruiz-Caro R., Veiga M.D., Carrageenan: Drug Delivery Systems and Other Biomedical Applications, „Marine Drugs” 2020, 18(11), 583. Tobacman J., Bhattacharyya S., Feferman L., Increase in Galectin-3 Contributes to Glucose Intolerance and Insulin Resistance following Exposure to the Common Food Additive Carrageenan, „Diabetes” 2018, 67, 780. Udo T. et al., Current and emerging applications of carrageenan in the food industry, „Food Research International” 2023, 173(2), 113369. Younes M. et al., Re‐evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives, „EFSA Journal” 2018, 16.
Diets Premium Expert
Diets Premium team expert. Specializes in nutrition plans, strength sports, and training plans.